PMID- 18955207
OWN - NLM
STAT- MEDLINE
DCOM- 20090309
LR  - 20081203
IS  - 1167-1122 (Print)
IS  - 1167-1122 (Linking)
VI  - 18
IP  - 6
DP  - 2008 Nov-Dec
TI  - Incidental cases of subacute cutaneous lupus erythematosus in association with 
      malignancy.
PG  - 700-4
LID - 10.1684/ejd.2008.0522 [doi]
AB  - Malignancy and chronic inflammatory diseases seem to be associated to one 
      another. Here we review the literature regarding subacute cutaneous lupus 
      erythematosus (SCLE) and concomitant neoplasia on the basis of 3 short case 
      reports of patients with SCLE who developed breast cancer and lung cancer 
      respectively after long-term disease activity and immunosuppressive therapy. 
      Possible hypotheses for this co-incidence could be: i) malignancy as a 
      consequence of chronic inflammation, ii) malignancy as a consequence of 
      immunosuppressive therapy, iii) paraneoplastic disease, iv) local malignancy 
      following a persisting proliferative or reparative process or v) only 
      coincidental occurrence.
FAU - Renner, Regina
AU  - Renner R
AD  - Clinic of Dermatology, Venereology und Allergology, University of Leipzig 
      Ph.-Rosenthalstr. 23-25, 04103 Leipzig, Germany. 
      regina.renner@medizin.uni-leipzig.de
FAU - Sticherling, Michael
AU  - Sticherling M
LA  - eng
PT  - Case Reports
PT  - Journal Article
DEP - 20081027
PL  - France
TA  - Eur J Dermatol
JT  - European journal of dermatology : EJD
JID - 9206420
SB  - IM
MH  - Breast Neoplasms/*complications
MH  - Female
MH  - Humans
MH  - Lung Neoplasms/*complications
MH  - Lupus Erythematosus, Cutaneous/*complications/drug therapy/pathology
MH  - Middle Aged
EDAT- 2008/10/29 09:00
MHDA- 2009/03/10 09:00
CRDT- 2008/10/29 09:00
PHST- 2008/07/21 00:00 [accepted]
PHST- 2008/10/29 09:00 [pubmed]
PHST- 2009/03/10 09:00 [medline]
PHST- 2008/10/29 09:00 [entrez]
AID - ejd.2008.0522 [pii]
AID - 10.1684/ejd.2008.0522 [doi]
PST - ppublish
SO  - Eur J Dermatol. 2008 Nov-Dec;18(6):700-4. doi: 10.1684/ejd.2008.0522. Epub 2008 
      Oct 27.